• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest

byShayna BejaimalandShaidah Deghan, MSc. MD
May 6, 2016
in Cardiology, Emergency
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial, administration of amiodarone or lidocaine did not provide a significant improvement in survival or neurological outcomes as compared to placebo in patients with shock-refractory out-of-hospital cardiac arrest.

2. There was a trend towards significance in the amiodarone vs. placebo comparison and it is unclear if the study’s initial amiodarone dosing of 150mg may have impacted these results.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Good-quality compressions and correct application of defibrillation are the only interventions that have mortality benefit in a cardiac arrest. Although the ACLS guidelines instruct one to give antiarrhythmic drugs like amiodarone or lidocaine, there has been no survival benefit. This randomized, double-blind trial aimed to determine the effect of amiodarone, lidocaine compared to saline placebo in adults with nontraumatic out-of-hospital shock-refractory cardiac arrest on survival and favourable neurological outcome.

Administration of the antiarrhythmics amiodarone or lidocaine did not have significant improvement on survival or neurological outcomes as compared to placebo. There was a trend towards significance in the amiodarone vs. placebo groups in both survival to discharge and neurological function at discharge. Of note is that the 2015 ACLS guidelines suggest an initial amiodarone loading dose of 300 mg. The study does not describe the reasons why the authors decided on using an initial dosing of 150 mg for amiodarone instead. Given the trend towards significance in comparing amiodarone and normal saline, it is unclear if this dosing change would have altered the study’s outcomes.

Click to read the study, published today in NEJM

Relevant Reading: 2015 American Heart Association Guidelines update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

RELATED REPORTS

#VisualAbstract: Endotracheal intubation offers no benefit over supraglottic airway in patients with out-of-hospital return of spontaneous circulation

Biomarkers demonstrate neuroprognostic accuracy for patients with hypoxic ischemic brain injury following cardiac arrest

Treatment of rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest

In-Depth [randomized controlled trial]: This randomized, double-blind trial was conducted at 10 North American sites from May 2012 to October 2015. Paramedics from these locations enrolled adult patients with nontraumatic out-of-hospital cardiac arrest and that had shock-refractory ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). The arrest was defined as shock-refractory if one or more shocks were used and the rhythm was nonterminating or recurrent after successful termination. These patients also required IV or IO vascular access. Patients were randomly assigned 1:1:1 to receive lidocaine, amiodarone or normal saline. All patients received the same standard post-cardiac care. The primary outcome was survival to hospital discharge. Secondary outcome was favourable neurological function at discharge as defined by the modified Rankin score. The primary analysis was per-protocol.

A total of 3026 patients were randomly assigned to amiodarone (N=974), lidocaine (N=993) or placebo (N=1059). The percentages of patients surviving to discharge were 24.4%, 23.7% and 21%, respectively. The difference in survival rate for amiodarone vs. placebo was 3.2% (95% [CI]: -0.4 to 7.0; p=0.08), lidocaine vs. placebo 2.6% (95% [CI]: -1.0 to 6.3; p=0.16) and between amiodarone and lidocaine 0.7% (95% [CI]: -3.2 to 4.7; p=0.70). Difference in neurological function at discharge for amiodarone vs. placebo was -0.14% (95% [CI]: -0.30 to 0.02; p=0.09), lidocaine vs. placebo -0.06% (95% [CI]: -0.22 to 0.10; p=0.45) and amiodarone vs. lidocaine -0.08% (95% [CI]: -0.24 to 0.08; p=0.34).

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiac arrest
Previous Post

Single-dose inactivated cholera vaccine regimen shows efficacy in Bangladesh

Next Post

Endometriosis linked to subsequent infertility risk

RelatedReports

#VisualAbstract: Endotracheal intubation offers no benefit over supraglottic airway in patients with out-of-hospital return of spontaneous circulation
StudyGraphics

#VisualAbstract: Endotracheal intubation offers no benefit over supraglottic airway in patients with out-of-hospital return of spontaneous circulation

April 13, 2022
Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage
Cardiology

Biomarkers demonstrate neuroprognostic accuracy for patients with hypoxic ischemic brain injury following cardiac arrest

April 7, 2022
Patient Basics: Electroencephalogram (EEG)
Cardiology

Treatment of rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest

March 2, 2022
Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage
Emergency

Endotracheal intubation offers no benefit over supraglottic airway in patients with out-of-hospital return of spontaneous circulation

February 24, 2022
Next Post

Endometriosis linked to subsequent infertility risk

2 Minute Medicine Rewind November 23 – November 30, 2014

Modified vaccinia Ankara booster increases immunogenic response in Ebola Virus disease

Elective colectomy associated with improved survival in ulcerative colitis

Ozanimod can inhibit immune system response and improve ulcerative colitis symptoms

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.